R-21 Colorectal Cancer Screening (CRCS) Pilot Trial



Status:Completed
Conditions:Colorectal Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:49 - 75
Updated:11/21/2018
Start Date:August 7, 2012
End Date:September 12, 2018

Use our guide to learn which trials are right for you!

Pilot Trial - Promoting Health Literacy for Colorectal Cancer Screening

The goal of this study is to test patient education program for decision making about
colorectal cancer (CRC) screening in community health centers.

Baseline Visit:

If you agree to take part in this study, you will complete a questionnaire that asks
demographic questions (such as your age and sex) and questions about colorectal cancer. It
should take about 10-15 minutes to complete.

You will be randomly assigned (as in the flip of a coin) to 1 of 2 groups. If you are in
Group 1, you will view a colorectal cancer program. If you are in Group 2, you watch a
program on Essential Hypertension.

You will watch the program on a laptop in the clinic. The program is about 30 minutes long.
After you watch the program, you will complete a questionnaire that asks what you thought
about the program and some questions about understanding medical information. It should take
about 5-10 minutes to complete the questionnaire.

You will be called 1-3 weeks after your baseline visit to complete a questionnaire by phone.
The call should last about 20-25 minutes. You will be asked if you discussed colorectal
cancer screening tests with your doctor, your preferences for colorectal cancer screening
tests, and if any colorectal cancer screening tests were ordered.

At Month 3, your medical record will be reviewed by the study staff.

Length of Study:

You will be off study after your medical record is reviewed at Month 3.

This is an investigational study.

Up to 180 participants (90 Hispanic and 90 African-American) will take part in this study.
All participants will be enrolled from the Harris County Hospital District and Kelsey-Seybold
outpatient clinics.

Inclusion Criteria:

1. Male or female patients

2. 49 -75 years of age

3. English-speaking African American or Spanish-speaking Hispanic patients (upon approval
of spanish language arm)

Exclusion Criteria:

1. History of colorectal cancer

2. History of polyps

3. Any inflammatory bowel disease (IBD), e.g. Crohn's disease or ulcerative colitis

4. Family history of colorectal cancer in a first degree relative

5. Had fecal occult blood test (FOBT) in the past year, flexible sigmoidoscopy in the
past 5 years or colonoscopy in the past 10 years
We found this trial at
1
site
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials